AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0010 (-25.00%)
Aug 19, 2026, 3:59 PM EST
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $1.09 million as of August 19, 2026. Its market cap has decreased by -38.73% in one year.
Market Cap
1.09M
Enterprise Value
n/a
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has decreased from 1.98M to 1.09M, a decrease of -44.98%. That is a compound annual growth rate of -4.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.09M | -71.37% |
| Dec 31, 2025 | 3.81M | 528.02% |
| Dec 31, 2024 | 605.90K | -86.58% |
| Dec 29, 2023 | 4.52M | -12.57% |
| Dec 30, 2022 | 5.16M | -91.35% |
| Dec 31, 2021 | 59.71M | 10.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| International Stem Cell | 2.80M |
| AccuStem Sciences | 2.51M |
| Bioxytran | 2.41M |
| VitaSpring Biomedical | 2.30M |
| Vaccinex | 2.23M |
| Bio-Path Holdings | 2.04M |
| Sirona Biochem | 1.35M |
| Neon Bloom | 1.27M |